SummerHaven Investment Management’s Puma Biotechnology PBYI Stock Holding History

SummerHaven Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.14M	Buy	+114,315	New	+$1.01M	0.63%	19

Other funds holding PBYI

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

SummerHaven Investment Management's PBYI Position: Q3 2026 in Review

SummerHaven Investment Management opened a new position in Puma Biotechnology (PBYI) in Q3 2026: 114,315 shares worth $1.14M. The stake represents 0.63% of the portfolio and ranks #19 among its holdings.

15 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

SummerHaven Investment Management held 114,315 shares of Puma Biotechnology worth $1.14M as of Q3 2026.
Puma Biotechnology was a new SummerHaven Investment Management position in Q3 2026.
Puma Biotechnology made up 0.63% of SummerHaven Investment Management's portfolio in Q3 2026, its #19 holding.
15 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on SummerHaven Investment Management's 13F filing for Q3 2026, filed 16 Oct 2026.